{"organizations": [], "uuid": "83cb3492bf9c45dc0c2c92009bc4a316fa4b4e54", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-revive-therapeutics-and-ehave-ente/brief-revive-therapeutics-and-ehave-enter-into-patient-research-data-collaboration-agreement-idUSFWN1QJ0ST", "country": "US", "domain_rank": 408, "title": "BRIEF-Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-01T14:10:00.000+02:00", "replies_count": 0, "uuid": "83cb3492bf9c45dc0c2c92009bc4a316fa4b4e54"}, "author": "", "url": "https://www.reuters.com/article/brief-revive-therapeutics-and-ehave-ente/brief-revive-therapeutics-and-ehave-enter-into-patient-research-data-collaboration-agreement-idUSFWN1QJ0ST", "ord_in_thread": 0, "title": "BRIEF-Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "ehave inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "rch data collaboration agreement reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 1, 2018 / 12:12 PM / in 7 minutes BRIEF-Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement Reuters Staff 1 Min Read March 1 (Reuters) - Ehave Inc: * REVIVE THERAPEUTICS AND EHAVE ENTER INTO PATIENT RESEARCH DATA COLLABORATION AGREEMENT FOR MEDICAL CANNABIS LIVER DISEASE PROGRAM Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-01T14:10:00.000+02:00", "crawled": "2018-03-01T14:25:44.010+02:00", "highlightTitle": ""}